AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012
May 10, 2012
30583_dirs_2012-05-10_4664fb93-5d9c-449d-b85f-e566e0a2dc2b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-04-30
Reporting Person: Wood Mark (VP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-04-30 | Common Stock | A | 480 | $27.906 | Acquired | 21114 | Direct |
| 2012-05-08 | Common Stock | A | 10000 | — | Disposed | 31114 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-08 | Stock Option (right to buy) | $37.46 | A | 25000 | Acquired | 2022-05-07 | Common Stock (25000) | Direct |
Footnotes
F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's Employee Stock Purchase Program ("ESPP"), purchase period of November 1, 2011 to April 30, 2012.
F2: Restricted stock units granted May 8, 2012. Price not applicable.
F3: Options vest on November 8, 2012 and 1/48th on the 8th of each month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19